UK less ready for next pandemic than before Covid – Oxford vaccinologist pharma The UK's state apparatus is less prepared to deal with a pandemic today than it was before Covid, one of the professors in charge of the Oxford Astrazeneca vaccine rollout has warned.
GSK: Good news for pharma giant as approval granted to expand vaccine use BUSINESS The FDA has expanded its approval of a GSK vaccine that prevents respiratory syncytial virus (RSV) to affect younger adults, in a move the company hopes will prevent thousands of hospitalisations each year.
Astrazeneca raises earnings forecast despite evaporation of Covid vaccine demand Shot in the arm For the third consecutive quarter, strong sales of AstraZeneca's blockbuster cancer treatments and healthy demand for its drugs in emerging markets offset the loss of sales of its COVID-19 vaccine and therapy.
Pfizer’s revenue drops over 50 per cent as Covid-19 vaccine sales wither August 1, 2023 US drugmaker Pfizer today reported that revenue more than halved during the second quarter of the year as global demand for its Covid-19 vaccines plummeted. It reported disappointing revenues of $12.7bn (£9.9bn) in the three months April to June – down 54 per cent, or $15bn, from the second quarter last year. Pfizer blamed the [...]
Moderna investors left disappointed by vaccine maker’s subdued sales forecast despite strong fourth quarter February 23, 2023 Moderna has reaffirmed annual sales forecast of $5bn (£4.1bn) for its Covid-19 vaccines despite its fourth-quarter sales exceeding estimates, on expectations of lower demand for the shots in the fourth year of the pandemic. Sales of the vaccine, Moderna’s sole commercial product, were expected to fall sharply this year from $18.4bn in 2022 as most people [...]
Astrazeneca’s shares rise, as cancer drug uptake offsets fall in sales of pharma giant’s Covid-19 vaccine February 9, 2023 Astrazeneca has posted what it claimed were “strong” financial results for the full year 2022 as surging demand for cancer medicines offset a fall in Covid vaccine revenues. Shares in Astrazeneca jumped on the news as the firm said it expects another year of double-digit revenue growth in 2023. The British firm’s strong results came [...]
Pfizer and BioNTech countersue Moderna in Covid-19 patent row December 6, 2022 Pfizer and German partner BioNTech shot back at competitor Moderna last night in the latest jab in the Covid-19 vaccine patent lawsuit. The sparring over allegations from Moderna that Pfizer and BioNTech violated the rights its three patents it created prior to the pandemic has been ongoing since August. All three companies are also embroiled [...]
Protect your health this winter November 30, 2022 | Sponsored As the nights draw in, it’s time to think about protecting our health this winter. We are preparing for a tough few months – with the potential for a further Covid-19 wave and a difficult flu season – and of course not everything can be prevented. But we can reduce the risk of Covid-19 and [...]
Novavax dials back revenue expectations despite Covid-19 jab success November 9, 2022 Novavax, an American biotech firm, has dialled back its revenue expectations, despite roaring success from its Covid-19 vaccine. In a statement last night, the company announced that it now forecasts full year revenue to be on the low end of its previously forecast range of between $2bn (£1.7bn) and $2.3bn (£2bn). The company, which was [...]
Moderna rejects request from China for Covid-19 vaccine technology October 2, 2022 Moderna has reportedly refused a request from China to reveal the technology behind its Covid-19 vaccine. The rejection prompted negotiations for its sale there to fall apart, the Financial Times reported, citing people familiar with the matter. The US pharmaceutical company remains “eager” to sell its product in China after negotiations between 2020 and 2021 [...]